Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Dexamethasone for Rebound Pain After Brachial Plexus Block
NCT06304909Phase 1Completed
- Sponsor
- Assiut University
- Start
- May 2024
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine and dexamethasone (3 arms), sponsored by Assiut University. Primary endpoint: Incidence of rebound pain at 1 year. Started May 2024; status: completed.
02
Drugs
dexmedetomidinedexamethasone
Beyond the preview
Go deeper on NCT06304909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06304909.